Cargando…

Disease-Modifying Activity of Huperzine A on Alzheimer’s Disease: Evidence from Preclinical Studies on Rodent Models

(1) Background: Huperzine A, a natural cholinesterase (AChE) inhibitor isolated from the Chinese herb Huperzia Serrata, has been used as a dietary supplement in the United States and a drug in China for therapeutic intervention on Alzheimer’s disease (AD). This review aims to determine whether Huper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Ye-Piao, Chen, Jia-Yue, Lu, Jia-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738397/ https://www.ncbi.nlm.nih.gov/pubmed/36499562 http://dx.doi.org/10.3390/ijms232315238

Ejemplares similares

Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer’s Disease?
por: Qian, Zhong Ming, et al.
Publicado: (2014)

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
por: Friedli, María Jesús, et al.
Publicado: (2021)

Dissolving microneedles for transdermal delivery of huperzine A for the treatment of Alzheimer's disease
por: Yan, Qinying, et al.
Publicado: (2020)

Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis
por: Xing, Shu-huai, et al.
Publicado: (2014)

Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
por: Zhang, Xiao-Wen, et al.
Publicado: (2020)

Huperzine A for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Yang, Guoyan, et al.
Publicado: (2013)

Ferulic Acid in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
por: Wang, Er-Jin, et al.
Publicado: (2021)

Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease
por: Meng, Qingqing, et al.
Publicado: (2018)

Examining the Interactome of Huperzine A by Magnetic Biopanning
por: Guo, Wei, et al.
Publicado: (2012)

Integration of System Biology Tools to Investigate Huperzine A as an Anti-Alzheimer Agent
por: Khanal, Pukar, et al.
Publicado: (2021)

The pharmacology and therapeutic potential of (−)-huperzine A
por: Tun, Maung Kyaw Moe, et al.
Publicado: (2012)

Huperzine A and Huperzine B Production by Prothallus Cultures of Huperzia selago (L.) Bernh. ex Schrank et Mart
por: Szypuła, Wojciech J., et al.
Publicado: (2020)

Huperzine A Ameliorates Cognitive Deficits in Streptozotocin-Induced Diabetic Rats
por: Mao, Xiao-Yuan, et al.
Publicado: (2014)

Rodent models of neuroinflammation for Alzheimer’s disease
por: Nazem, Amir, et al.
Publicado: (2015)

Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection
por: Yang, Xin, et al.
Publicado: (2020)

In Vitro Propagation, Huperzine A Content and Antioxidant Activity of Three Genotypic Huperzia serrata
por: Yang, Yan, et al.
Publicado: (2021)

Huperzine A-Liposomes Efficiently Improve Neural Injury in the Hippocampus of Mice with Chronic Intermittent Hypoxia
por: Yang, Xin-Yue, et al.
Publicado: (2023)

Neural stem/progenitor cell therapy for Alzheimer disease in preclinical rodent models: a systematic review and meta-analysis
por: Zhou, Zijing, et al.
Publicado: (2023)

The effects of huperzine A on gastrointestinal acetylcholinesterase activity and motility after single and multiple dosing in mice
por: ZHANG, LEIMING, et al.
Publicado: (2013)

Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease
por: Faridar, Alireza, et al.
Publicado: (2022)

The complete mitochondrial genome of huperzine A-producing endophytic fungus Penicillium polonicum
por: Kang, Xincong, et al.
Publicado: (2016)

Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
por: Bosco, Francesca, et al.
Publicado: (2023)

Huperzine A attenuates nonalcoholic fatty liver disease by regulating hepatocyte senescence and apoptosis: an in vitro study
por: Hu, Xiao-na, et al.
Publicado: (2018)

Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
por: Cuello, A. Claudio, et al.
Publicado: (2019)

Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake
por: Li, Fang, et al.
Publicado: (2017)

Revisiting rodent models: Octodon degus as Alzheimer’s disease model?
por: Steffen, Johannes, et al.
Publicado: (2016)

The temporal and spatial endophytic fungal community of Huperzia serrata: diversity and relevance to huperzine A production by the host
por: Shen, Zhuhui, et al.
Publicado: (2022)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
por: Qin, Wei, et al.
Publicado: (2022)

Preclinical Evidence and Possible Mechanisms of Extracts or Compounds from Cistanches for Alzheimer’s Disease
por: Zhou, Xiao-Li, et al.
Publicado: (2019)

Huperzine—A Improved Animal Behavior in Cuprizone-Induced Mouse Model by Alleviating Demyelination and Neuroinflammation
por: Zhang, Hongyu, et al.
Publicado: (2022)

Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease
por: Assunção, Sheila Seleri, et al.
Publicado: (2022)

APP mouse models for Alzheimer's disease preclinical studies
por: Sasaguri, Hiroki, et al.
Publicado: (2017)

Huperzine A protects against traumatic brain injury through anti-oxidative effects via the Nrf2-ARE pathway
por: Mei, Zhengrong, et al.
Publicado: (2021)

Experimental Rodent Models of Cardiovascular Diseases
por: Jia, Tian, et al.
Publicado: (2020)

Ultrastructural mitochondria changes in perihematomal brain and neuroprotective effects of Huperzine A after acute intracerebral hemorrhage
por: Lu, Haiying, et al.
Publicado: (2015)

Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer’s disease therapeutic
por: Kang, Min Su, et al.
Publicado: (2021)

Allopregnanolone Promotes Regeneration and Reduces β-Amyloid Burden in a Preclinical Model of Alzheimer's Disease
por: Chen, Shuhua, et al.
Publicado: (2011)

Isolation of endophytic fungi and screening of Huperzine A–producing fungus from Huperzia serrata in Vietnam
por: Thi Minh Le, Thanh, et al.
Publicado: (2019)

An Algorithm for Preclinical Diagnosis of Alzheimer's Disease
por: Khan, Tapan K.
Publicado: (2018)

Endophytic Fungal Community of Huperzia serrata: Diversity and Relevance to the Production of Huperzine A by the Plant Host
por: Cui, Lingli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vshmklrcb377ce1e2b1i2l90it